Instituto de Diagnóstico S.A. (SNSE:INDISA)

Chile · Delayed Price · Currency is CLP

2,678.60

-20.40 (-0.76%)

At close: Jun 18, 2026

27.55% (1Y)

Market Cap	410.98B +39.1%
Revenue (ttm)	280.84B +14.4%
Net Income	13.91B +60.4%
EPS	94.74 +54.0%
Shares Out	153.43M
PE Ratio	28.27
Forward PE	n/a
Dividend	15.50 (0.58%)
Ex-Dividend Date	May 19, 2026

Volume	3,876
Open	2,687.60
Previous Close	2,699.00
Day's Range	2,672.60 - 2,687.60
52-Week Range	2,100.00 - 2,935.90
Beta	0.38
Analysts	Hold
Price Target	1,900.00 (-29.07%)
Earnings Date	Sep 4, 2026

About Instituto de Diagnóstico

Instituto de Diagnóstico S.A. provides health services in Chile. It offers patient information and exams instruction, and online services; specialties services; and outpatient services including urgency, laboratory, imaging, vaccination, blood bank, outpatient procedures, and reproductive medicine unit. The company also provides hospitalization services, such as maternity, adult and pediatric hospitalization, adult critical patient unit, pavilion and surgical procedures, neonatology, and robotic surgery; and telemedicine services comprising onl... [Read more]

Industry Medical Care Facilities

Sector Healthcare

Founded 1961

Employees 3,091

Stock Exchange Santiago Stock Exchange

Ticker Symbol INDISA

Full Company Profile

Financial Performance

In 2025, Instituto de Diagnóstico's revenue was 272.31 billion, an increase of 13.90% compared to the previous year's 239.07 billion. Earnings were 15.66 billion, an increase of 115.23%.

Financial Statements